JA
John H Abeles

John H Abeles insider trades: Medite Cancer Diagnostics (MDIT) stock buys and sales

Medite Cancer Diagnostics Last trade Oct 11, 2018 34 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2005
8
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

and 2 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 11, 2018MDIT↑ Buy$20K
Jul 3, 2018MDIT↑ Buy$30K
Dec 17, 2009DUSA↑ Buy$51K
Nov 13, 2007DUSA↑ Buy$10K
Aug 10, 2007IFLO↓ Sell$49K
Aug 9, 2007IFLO↓ Sell$286K
Sep 14, 2005IFLO↓ Sell$28K
Sep 13, 2005IFLO↓ Sell$191K
Jul 22, 2005ORYX↑ Buy$11K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John H Abeles's insider trades

John H Abeles is an insider at Medite Cancer Diagnostics (MDIT). Since Jul 22, 2005, John has reported 5 open-market purchases worth $122K and 4 sales worth $554K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (22 filings), other transactions (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDIT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.